Novo Nordisk NVO shares have lost 16.7%, attributable to both sector-specific developments and broader macroeconomic ...

The market expects Eli Lilly (LLY) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is ...

Eli Lilly says a new starting dose regimen for its Alzheimer's disease therapy Kisunla reduces the risk of side effects that have stood in the way of approvals and reimbursement decisions for ...

Wall Street’s Evan David Seigerman stirred the pot by slashing his price target on Eli Lilly stock—but not his enthusiasm.

The fund's momentum bias helped produce particularly strong performance from 2017 through 2020 as the market rewarded high-multiple stocks with lofty expectations for future growth. Top picks over ...

Suzlon down 16% in 2025, but with a 21% upside projected by Motilal Oswal. Is this the right time to… ...

The U.S. wholesale market for wine and spirits is projected to eke out an increase in revenue terms this year, despite pressure on disposable incomes, higher trade hurdles, and weaker growth across ...

Bonus Dec 03, 2024 Dec 03, 2024 Oct 17, 2024 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Mar 06, 2019 Mar 07, 2019 Jan 18, 2019 Bonus Ratio: 1 share(s) for every 3 shares held Bonus Jun 13, ...